glp-1 release Frontiers Schematic illustration of GLP-1 release

The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend considering GLP-1R agonists for T2DM patients who do not have established CVD but are at high risk for ASCVD

Frequently Asked Questions How do Oral Compounded GLP-1 drops work

Al-Aly thinks that might be an underestimate because even though the study followed huge numbers of people, it covered only about four years, so they might have seen more Alzheimers cases if the study had gone on for longer, which might have translated to a larger benefit

Rare Disease Day Webinar: Voices that move systems Access the webinar replay offering actionable, cross-geography insights on how patient and caregiver voices can improve diagnosis, engagement, and outcomes